18 million cases of cancer were diagnosed worldwide in 2020. And 1 in 2 people will get cancer in their lifetime. We are fundraising to support Cancer Research UK as they focus on making discoveries, driving progress and bringing hope to those affected by cancer.
Cancer is the second leading cause of death worldwide, accounting for an estimated 10 million deaths in 2020.
The economic burden of cancer is enormous, with estimates suggesting that it costs the global economy over $1.1 trillion annually in healthcare expenditure and lost productivity.
Cancer research has led to significant advances in prevention, detection, and treatment over the past few decades, but there is still much to be done. Many types of cancer remain difficult to treat, and there is a need for more targeted and personalized therapies.
The COVID-19 pandemic has had a significant impact on cancer research funding, with many organizations and governments redirecting resources towards pandemic-related research and response. This has resulted in a funding gap for cancer research that needs to be addressed to continue to progress.
Many cancers can be cured if detected early and treated effectively. CRUK partners internationally with a number of organisations, including the American Association for Cancer Research (AACR) alliance. Their trans-Atlantic alliance with the American Association for Cancer Research has accelerated the pace of progress against cancer by facilitating collaborations between scientists in the US and UK.
Cancer Research UK is dedicated to saving lives through research. Their mission is to prevent, control and cure cancer through ground-breaking research and in the last 40 years their work has helped double survival rates. But there is more work to be done. The only charity fighting over 200 types of cancer, they rely on every pound donated to help get all of us closer to beating cancer.
By raising funds for Cancer Research UK, this enables scientists to continue to explore brave new ways to fight the disease and develop radical treatments, meaning more people diagnosed with cancer can become long-term survivors.